Phenotypic Disease Modeling for Immuno-Oncology: Putting Targets into Patient Context
Phenotypic Disease Modeling for Immuno-Oncology: Putting Targets into Patient Context
Watch our on-demand webinar with Henriëtte Lanz, PhD (Vice President Biology at MIMETAS). Dive deep into MIMETAS’ expertise in disease modeling and drug screening within the field of immuno-oncology. The webinar explores, among other topics, the immuno-suppressive and stimulatory nature of the tumor microenvironment (TME) in hepatocellular carcinoma.
Phenotypic Disease Modeling for Immuno-Oncology: Putting Targets into Patient Context
Watch our on-demand webinar with Henriëtte Lanz, PhD (Vice President Biology at MIMETAS). Dive deep into MIMETAS’ expertise in disease modeling and drug screening within the field of immuno-oncology. The webinar explores, among other topics, the immuno-suppressive and stimulatory nature of the tumor microenvironment (TME) in hepatocellular carcinoma.
Phenotypic Disease Modeling for Immuno-Oncology: Putting Targets into Patient Context
Watch our on-demand webinar with Henriëtte Lanz, PhD (Vice President Biology at MIMETAS). Dive deep into MIMETAS’ expertise in disease modeling and drug screening within the field of immuno-oncology. The webinar explores, among other topics, the immuno-suppressive and stimulatory nature of the tumor microenvironment (TME) in hepatocellular carcinoma.
Phenotypic Disease Modeling for Immuno-Oncology: Putting Targets into Patient Context
Watch our on-demand webinar with Henriëtte Lanz, PhD (Vice President Biology at MIMETAS). Dive deep into MIMETAS’ expertise in disease modeling and drug screening within the field of immuno-oncology. The webinar explores, among other topics, the immuno-suppressive and stimulatory nature of the tumor microenvironment (TME) in hepatocellular carcinoma.
Phenotypic Disease Modeling for Immuno-Oncology: Putting Targets into Patient Context
Watch our on-demand webinar with Henriëtte Lanz, PhD (Vice President Biology at MIMETAS). Dive deep into MIMETAS’ expertise in disease modeling and drug screening within the field of immuno-oncology. The webinar explores, among other topics, the immuno-suppressive and stimulatory nature of the tumor microenvironment (TME) in hepatocellular carcinoma.
Phenotypic Disease Modeling for Immuno-Oncology: Putting Targets into Patient Context
Watch our on-demand webinar with Henriëtte Lanz, PhD (Vice President Biology at MIMETAS). Dive deep into MIMETAS’ expertise in disease modeling and drug screening within the field of immuno-oncology. The webinar explores, among other topics, the immuno-suppressive and stimulatory nature of the tumor microenvironment (TME) in hepatocellular carcinoma.
Phenotypic Disease Modeling for Immuno-Oncology: Putting Targets into Patient Context
Watch our on-demand webinar with Henriëtte Lanz, PhD (Vice President Biology at MIMETAS). Dive deep into MIMETAS’ expertise in disease modeling and drug screening within the field of immuno-oncology. The webinar explores, among other topics, the immuno-suppressive and stimulatory nature of the tumor microenvironment (TME) in hepatocellular carcinoma.
Phenotypic Disease Modeling for Immuno-Oncology: Putting Targets into Patient Context
Watch our on-demand webinar with Henriëtte Lanz, PhD (Vice President Biology at MIMETAS). Dive deep into MIMETAS’ expertise in disease modeling and drug screening within the field of immuno-oncology. The webinar explores, among other topics, the immuno-suppressive and stimulatory nature of the tumor microenvironment (TME) in hepatocellular carcinoma.